TABLE 1

Demographic information for type 2 diabetic patient and control populations

African-American case subjects, round 1African-American control subjects, round 1African-American case subjects, round 2African-American control subjects, round 2European-American case subjectsEuropean-American control subjects
Total380276851*635300310
Female60.5 (230)63.8 (176)61.5 (523)52.0 (330)53.0 (159)70.6 (219)
Age (years)63.4 ± 10.8 (353)a,b,cN/A61.2 ± 10.1 (801)a,d,e,f50.5 ± 10.1 (332)b,d,g,h65.8 ± 10.3 (207)e,g,i45.8 ± 15.2 (164)c,f,h,i
Type 2 diabetes diagnosis (years)42.8 ± 11.8 (373)j,k40.4 ± 12.0 (801)j,e46.5 ± 12.8 (296)k,e
ESRD diagnosis (years)60.1 ± 10.2 (375)k,l57.7 ± 10.5 (830)e,l63.6 ± 10.2 (298)e,k
BMI (kg/m2)29.3 ± 7.3 (373)cN/A29.8 ± 7.2 (819)f,m29.5 ± 6.7 (336)h28.5 ± 7.0 (297)m,n25.7 ± 3.9 (65)c,f,h,n
  • Data are n, n (%), or the means ± SD (n).

  • *

    * Includes the 380 African-American case subjects from round 1 genotyping;

  • includes the 276 control subjects from round 1 genotyping.

  • a,m,n

    a,m,n P < 0.05;

  • j

    j P < 0.01;

  • b,c,d,e,f,g,h,i,k,l

    b,c,d,e,f,g,h,i,k,l P < 0.001.